Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for VICTOZA
- Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
- A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants With Type 1 Diabetes
- A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
- Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
- A Randomized Phase 1 Study of Liralutide Injection in Healthy Chinese Subjects
- Liraglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
- Human Bioequivalence Test of Liraglutide Injection
- The Effect and the Pharmacogenomics Study of Liraglutide in Obese Patients
- Efficacy of Liraglutide Therapy in Patients With IPAA
- Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia
- Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients
- Study to Assess the Efficacy and Safety of Liraglutide in the Treatment of Type 2 Diabetes
- Liraglutide in the Prevention of Type 2 Diabetes After Gestational Diabetes
- Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease
- The Effect of Liraglutide on the GIT
- Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients
- Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabetes Mellitus
- Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
- Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
- Pilot Study of the Effect of Liraglutide 3.0 mg on Weight Loss and Gastric Functions in Obesity
- Comparing Efficacy and Safety of CinnaGen-liraglutide Versus Victoza® in Patients With Type II Diabetes
- Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Clinical Efficacy and Safety of Using 3.0mg Liraglutide to Treat Weight Regain After Roux-en-Y Gastric Bypass Surgery
- A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus
- Safety and Efficacy of Liraglutide in Parkinson's Disease
- Antigen-Lipid-Driven Monoclonal Gammopathies Targeting Epicardial Fat
- Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity
- GLP-1/Basal Insulin Combination Therapy
- HbA1c Variability in Type II Diabetes
- Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes
- Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
- Effects of Single Doses of Liraglutide and Dapagliflozin on Hyperglycemia and Ketogenesis in Type 1 Diabetes
- The Effect of Liraglutide Treatment on Postprandial Chylomicron and VLDL Kinetics, Liver Fat and de Novo Lipogenesis
- Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes
- Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans
- Effect of Victoza on Dietary Preferences and Habit in Patients With Type 2 Diabetes
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian Descent
- Effect of Liraglutide on Diastolic Dysfunction on Cardiac MRI in Type 2 Diabetes Patients
- Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults
- Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood
- Pilot Study of the Effect of Liraglutide on Weight Loss and Gastric Functions in Obesity
- Preoperative Condition in Giant Obese Patients
- Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
- Antiproteinuric Effects of Liraglutide Treatment
- Par-4 and Telomere-telomerase System in Type 2 Diabetes Patients Who Received GLP-1 or Metformin Treatment
- Treatment of Hypoglycemia Following Gastric Bypass Surgery
- Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
- Liraglutide in Adolescents With Type 1 Diabetes
- A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
- The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
- Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
- Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid
- Investigating the Effect of Liraglutide on the Endogenous Glucose Production During in Tye 1 Diabetes Subjects
- The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
- The Lira Pump Trial
- Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes
- Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients
- Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)
- Liraglutide to Improve corONary Haemodynamics During Exercise streSS
- To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study
- Effect of Cycloset on Glycemic Control When Added to Glucagon-like Peptide 1 (GLP-1) Analogue Therapy
- Trial for People With Established Type 2 Diabetes During Ramadan
- Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)
- The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
- Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
- Effects of Victoza® Versus Lyxumia® on Gastroesophageal Reflux, Gastric Emptying and Gastric Acid Secretion
- Liraglutide Actions on the Liver: Effects on Glucose Phosphorylation
- Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes
- Addition of Liraglutide to Patients With Type 2 Diabetes Treated With Multiple Daily Insulin Injections
- Effect of Repeated Administration of Liraglutide on Insulinogenic Indices
- A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
- Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
- Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)
- Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
- Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes Mellitus
- Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
- Antidiabetic Effects of Adding a DPP-4 Inhibitor to Pre-Existing Treatment With an Incretin Mimetic in Patients With T2D
- Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.
- Liraglutide Hospital Discharge Trial
- Liraglutide in Newly Onset Type 1 Diabetes.
- Effect of Liraglutide on Automated Closed-loop Glucose Control in Type 1 Diabetes
- Does a GLP-1 Receptor Agonist Change Glucose Tolerance in Antipsychotic-treated Patients?
- Evaluating Liraglutide in Alzheimer's Disease
- A Pilot Study of the Effects on Sleep Disordered Breathing (SDB) When Using the Drug Liraglutide for 4 Weeks
- Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus
- Functional Impact of GLP-1 for Heart Failure Treatment (FIGHT)
- The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes
- 52 Week Trial of Liraglutide in Type 1 Diabetes
- Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
- Incretin Effect on the Immunological Phenotype
- RISE Adult Medication Study
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
- Blood Pressure Outcomes With Liraglutide Therapy
- GLP-1 and Microvascular Function in Type 2 Diabetes
- Influence of Appetite Related Hormones in Binge Eating Behaviour Among the Overweight and Obese
- To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes
- Liraglutide in the Treatment of Type 1 Diabetes Mellitus
- The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers
- Effects of Liraglutide on Kidney Function in Type 2 Diabetic Patients
- Study of Effectiveness of Liraglutide Added to High Dose Insulin in Type II Diabetics
- GLP-1 and Non-exercise Activity Thermogenesis in RHZ
- Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
- Liraglutide in Type 1 Diabetes
- The Effects of GLP-1 in Maturity-Onset Diabetes of The Young (MODY)
- Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients
- Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI
- Liraglutide Effects on Memory in Healthy Subjects
- Liraglutide Use in Prader-Willi Syndrome
- Vildagliptin Versus Liraglutide - Patient Preference After Receiving Both Medications
- Adding Liraglutide to High Dose Insulin: Breaking the Cycle
- Time Course of the Blood Pressure Lowering Effect of Liraglutide Therapy in Type 2 Diabetes
- The Effect of Liraglutide on Left Ventricular Function in Chronic Heart Failure Patients With and Without Type 2 Diabetes Mellitus
- The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis
- Evaluating the Safety and Effectiveness of Liraglutide in Subjects With Type 2 Diabetes
- Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes
- Liraglutide Treatment to Patients With Severe Renal Insufficiency
- Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes
- Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin
- LIraglutide and Beta-cell RepAir (LIBRA) Study
- Liraglutide Efficacy and Action in Non-Alcoholic Steatohepatitis
- Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
- Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
- Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes
- Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
- Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes
Clinical trials list
click for details